Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

GABAPENTIN Drug Profile

« Back to Dashboard

Which patents cover Gabapentin, and what generic Gabapentin alternatives are available?

Gabapentin is a drug marketed by Sciegen Pharms Inc, Alkem Labs Ltd, Acella Pharms Llc, Invagen Pharms, Ranbaxy, Sun Pharm Inds Ltd, Marksans Pharma, Teva Pharms Usa, Ivax Sub Teva Pharms, Sandoz, Amneal Pharms, Zydus Pharms Usa Inc, Teva, Amneal Pharms Ny, Teva Pharms, Mylan Pharms Inc, Sun Pharm Inds, Aci Healthcare Ltd, Actavis Elizabeth, Hikma, Aurobindo Pharma Ltd, Alkem, Mylan, Apotex Inc, Taro Pharm, Glenmark Generics, Taro, Hi Tech Pharma, Hikma Pharms, Watson Labs, Tris Pharma Inc, and Epic Pharma Llc. and is included in forty-four NDAs.

The generic ingredient in GABAPENTIN is gabapentin. There are twenty-six drug master file entries for this compound. One hundred and three suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the gabapentin profile page.

Summary for Tradename: GABAPENTIN

Patents:0
Applicants:32
NDAs:44
Suppliers / Packagers: see list100
Bulk Api Vendors: see list93
Clinical Trials: see list102
Patent Applications: see list6,333
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GABAPENTIN at DailyMed

Pharmacology for Tradename: GABAPENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm
GABAPENTIN
gabapentin
CAPSULE;ORAL077261-001Aug 2, 2013ABRXNoNo► Subscribe► Subscribe
Actavis Elizabeth
GABAPENTIN
gabapentin
TABLET;ORAL075694-002Oct 21, 2004ABRXNoNo► Subscribe► Subscribe
Teva Pharms
GABAPENTIN
gabapentin
CAPSULE;ORAL075435-003Oct 8, 2004ABRXNoNo► Subscribe► Subscribe
Teva
GABAPENTIN
gabapentin
TABLET;ORAL075827-002Dec 15, 2004DISCNNoNo► Subscribe► Subscribe
Sandoz
GABAPENTIN
gabapentin
TABLET;ORAL076877-001Jul 6, 2006DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot